Atormac
briv
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 489  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (578 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this Article
   References
   Article Figures

 Article Access Statistics
    Viewed2113    
    Printed35    
    Emailed1    
    PDF Downloaded42    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
LETTER TO EDITOR
Year : 2014  |  Volume : 62  |  Issue : 2  |  Page : 214-216

A giant falcine chondrosarcoma: Case report and literature review


Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China

Date of Submission22-Sep-2013
Date of Decision17-Dec-2013
Date of Acceptance31-Mar-2014
Date of Web Publication14-May-2014

Correspondence Address:
Qing Mao
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.132429

Rights and Permissions



How to cite this article:
Yang YW, Liu S, Wang X, Mao Q. A giant falcine chondrosarcoma: Case report and literature review. Neurol India 2014;62:214-6

How to cite this URL:
Yang YW, Liu S, Wang X, Mao Q. A giant falcine chondrosarcoma: Case report and literature review. Neurol India [serial online] 2014 [cited 2021 May 9];62:214-6. Available from: https://www.neurologyindia.com/text.asp?2014/62/2/214/132429


Sir,

Parafalcine chondrosarcoma is extremely rare and may be difficult to differentiate preoperatively from falx meningioma. We report yet another such rare case.

A 26-year-old male presented with a 3-week history of progressive headache and right hand numbness. Neurological examination revealed decrease in proprioception in the right hand. Cranial magnetic resonance imaging (MRI) revealed a well-marginated parafalx mass (9.4 × 6.4 × 6.0 cm) occupying bilateral frontal lobes and along the falx cerebri. It was hypointense on T1-weighted and hyperintense on T2-weighted images [Figure 1]a with no perilesional edema. Contrast-enhanced MRI scan showed a lobulated heterogeneously enhanced honeycomb lesion [Figure 1]b. Preoperative diagnosis was parafalcine meningioma and MR venography (MRV) showed oppression of superior sagittal sinus by the tumor [Figure 1]c. Total resection of the tumor was performed by bicoronal craniotomy. The lesion was hard, lobulated, gray-white, with a very firm cartilaginous consistency. The tumor and the dural attachment were totally removed. Regular follow-up MRI scans at 18 months showed no recurrence [Figure 1]d. She has recovered well and is able to run again. Microscopic examination revealed lobulated appearance with variable low to moderate cellularity composed primarily of individual cells separated by a basophilic matrix. Neoplastic chondrocytes had plump and hyperchromatic nuclei with few mitotic figures [Figure 2]. Immunohistochemical studies demonstrated positivity for S-100, which is consistent with the diagnosis of a cartilaginous tumor [Figure 3].
Figure 1: Imaging appearances of the intracranial chondrosarcoma. (a) Axial T2-weighted image reveals a bilateral frontal mass and has high signal intensity relative to cortex, with the low signal areas representing probable calcification (b) Axial contrast-enhanced T1-weighted image shows a lobulated heterogeneously enhanced tumor (c) MRV shows a part of the superior sagittal sinus that was oppressed by the tumor (d) There was no sign of recurrence at 18-month follow-up MRV = Magnetic resonance venography

Click here to view
Figure 2: High-power view of the surgical specimen shows neoplastic chondrocytes with moderate cellular atypia with identifiable nuclei

Click here to view
Figure 3: The cartilaginous portion of the tumor was positive for S-100 protein

Click here to view


Chondrosarcomas are malignant tumors of cartilage and may arise from bone or soft tissues. [1] They account for 6% of skull = base neoplasms and 0.15% of all intracranial tumors. [2] Approximately 75% of all cranial chondrosarcomas occurs at the base of the skull and mostly in the middle cranial fossa. [3],[4] The rare locations include the following: Choroid plexus, dura mater, and intraparenchymal. Only 61 cases of dural origin have been reported to date and of them only nine were classic low-grade type. [5],[6],[7],[8] Skull-based chondrosarcomas are most commonly classic type, [3] but about 62% dural-based chondrosarcomas are mesenchymal variant. [5] The variants of parafalcine chondrosarcomas have a strong female preponderance, clinical symptoms at onset were similar to falx meningiomas and the preoperative diagnosis was frequently meningioma.

Chondrosarcomas are classified into the classic, mesenchymal, and myxoid subtypes based on the histologic architecture; these variants significantly differ in clinical presentation and prognosis. Classic chondrosarcoma is easily distinguished from the mesenchymal variant by its well-differentiated structure with few or no mesenchymal components and from the myxoid variant, by the absence of myxoid stroma. The mesenchymal subtypes are the most malignant of the three, illustrated by a strong tendency for intradural and cerebral growth, and occasionally distant metastases. [3]

On computed tomography (CT) scans, these lesions are usually isodense to hyperdense, with variable degrees of heterogeneous enhancement. These tumors have varying amounts of histologic and radiologic calcifications, but falcine chondrosarcomas show lesser calcification compared with skull-base variants. MRI offers better demarcation of the lesion and tumor characterization. These tumors are frequently hypointense on T1-weighted images and extremely hyperintense on T2-weighted images. They show some mild or moderate degree of contrast enhancement and may have a honeycomb appearance. [9] The absence of a dural tail, minimal vasogenic edema, and relative avascularity on angiography could be the characteristics for differential diagnosis.

The most important differentials include falx or parasagittal meningioma, hemangiopericytoma, metastasis, and vascular malformations. Higher signal intensity on the T2-weighted MRI, islands of low signal intensity despite lack of gross calcification on all the sequences due to well-differentiated cartilage, "honeycomb" appearance on contrast enhancement, and lack of perfusion may differentiate chondrosarcomas from meningiomas. [9] The relative absence of edema can also be used to distinguish it from tumors such as glioblastomas and metastases. Lack of vascularity and absence of flow voids differentiate it from a vascular malformation or the mesenchymal variety. To specially mention, none of the MRI or CT features appear to be useful for differentiating chordomas from chondrosarcomas preoperatively. [10]

Radical surgical resection is the preferred treatment modality. The widest possible resection seems to be a significant prognostic factor. Chondrosarcomas at the skull base have a strong tendency for local recurrence due to the difficulty of complete resection. In a report by Korten et al., [3] 53% of patients had recurrence attributed to partial resection due to the proximity of the lesion to critical neuronal and vascular structures. However, no recurrences have been reported to date in dural-based classical chondrosarcomas. [5],[6],[7],[8] Mesenchymal and myxoid subtype indicates worse clinical behavior and poorer prognosis than conventional histology. About 50% of the mesenchymal and nearly all the myxoid variants showed recurrence. [3] Some authors recommend adjuvant radiation therapy to prevent recurrence, but it is difficult to tell if this mode of adjuvant therapy is effective because the few cases prohibit drawing any conclusions about such treatment.

 
  References Top

1.Alvira MM, McLaurin RL. Asymptomatic subdural chondrosarcoma. Case report. J Neurosurg 1978;48:825-8.  Back to cited text no. 1
[PUBMED]    
2.Kretzschmar HA, Eggert HR, Beck U, Furmaier R. Intracranial chondroma. Case report. Surg Neurol 1989;32:121-5.  Back to cited text no. 2
    
3.Korten AG, ter Berg HJ, Spincemaille GH, van der Laan RT, Van de Wel AM. Intracranial chondrosarcoma: Review of the literature and report of 15 cases. J Neurol Neurosurg Psychiatry 1998;65:88-92.  Back to cited text no. 3
    
4.Sorimachi T, Sasaki O, Nakazato S, Koike T, Shibuya H. Myxoid chondrosarcoma in the pineal region. J Neurosurg 2008;109:904-7.  Back to cited text no. 4
    
5.Krishnan SS, Panigrahi M, Varma D, Madigubba S. Falcine and parasagittal intracranial chondrosarcomas of the classical variant: Report of two cases with review of literature. Neurol India 2011;59:451-4.  Back to cited text no. 5
[PUBMED]  Medknow Journal  
6.Kan Z, Li H, Zhang J, You C. Intracranial mesenchymal chondrosarcoma: Case report and literature review. Br J Neurosurg 2012;26:912-4.  Back to cited text no. 6
    
7.Lin HS, Tsai CC, Chang CK, Chen SJ. Giant intracranial mesenchymal chondrosarcoma with uncal herniation. Fo J Surg 2012;45:93-6.  Back to cited text no. 7
    
8.Altinbo AA, Yalcin N, Akbulut M, Coskun E, Duzcan SE. Intracranial chondrosarcoma in a 22-years old woman: Report of a case. J Neurological S (Turk) 2011;28:614-8.  Back to cited text no. 8
    
9.Güneþ M, Günaldi O, Tuðcu B, Tanriverdi O, Güler AK, Cöllüoðlu B. Intracranial chondrosarcoma: A case report and review of the literature. Minim Invasive Neurosurg 2009;52:238-41.  Back to cited text no. 9
    
10.Pamir MN, Ozduman K. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas. Eur J Radiol 2006;58:461-70.  Back to cited text no. 10
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow